Jane Smith
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
New Perspectives on the Risk of Secondary Cancers After CAR T-cell Therapy
Learn MoreEditors’ Picks: Highlights from AACR Journals
Learn MoreSecond CAR T–cell Therapy Approved by the FDA
Learn MoreAACR to Host Virtual Meeting on Clonal Hematopoiesis
Learn MoreAACR 2024 Plenary Program Kicks Off With New Insights Into Early Cancer Biology
Learn MoreHow Do We Overcome Endocrine Therapy Resistance in Breast Cancers?
Learn MoreStepping Into the Era of Combination Cancer Therapies, Part 2: Combining Targeted Therapies
Learn MoreNCI Collection Offers a Look at “Cancer Close Up”
Learn MoreExpert Panel Releases Recommendations to Support Cancer Moonshot Initiative
Learn MoreHow Will Artificial Intelligence Change Cancer Care?
Learn MoreWe have made spectacular progress against cancer thanks to breakthroughs in cancer science. However, with more than 600,000 people in the United States projected to die from cancer this year, our work is not done. Get involved to ensure that the momentum continues: